Detalles de la búsqueda
1.
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Int J Obes (Lond)
; 47(11): 1143-1151, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653071
2.
Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety.
Obes Rev
; 25(5): e13717, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38463003
3.
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.
EClinicalMedicine
; 69: 102475, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38544798
4.
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
Lancet Healthy Longev
; 5(5): e314-e325, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588687
5.
Increased meal-induced neurotensin response predicts successful maintenance of weight loss - Data from a randomized controlled trial.
Metabolism
; 143: 155534, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36933790
6.
Effects of vegan diets on cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials.
Obes Rev
; 23(9): e13462, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672940
7.
Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment.
Nat Commun
; 13(1): 4770, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970829
8.
Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness.
Diabetes Care
; 44(1): 224-230, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208488
9.
[The glucagon-like peptide-1 receptor-agonist semaglutide].
Ugeskr Laeger
; 181(41)2019 Oct 07.
Artículo
en Danés
| MEDLINE | ID: mdl-31610830
10.
Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet.
BMJ Open
; 9(11): e031431, 2019 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678947
11.
Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
J Diabetes Res
; 2017: 7583506, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29082261
12.
Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity.
Obes Facts
; 10(6): 633-647, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29207396
13.
Glucagon-like peptide-1 receptor agonists: the key to healthy weight loss maintenance?
Cardiovasc Res
; 117(10): e120-e122, 2021 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448813
14.
Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance.
J Clin Endocrinol Metab
; 101(4): 1372-80, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26815880
15.
Liraglutide for Type 2 diabetes and obesity: a 2015 update.
Expert Rev Cardiovasc Ther
; 13(7): 753-67, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26106933
16.
Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL.
Cardiovasc Res
; 114(10): e70-e71, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30052921
Resultados
1 -
16
de 16
1
Próxima >
>>